Form 8-K - Current report:
SEC Accession No. 0000950170-22-005374
Filing Date
2022-04-05
Accepted
2022-04-05 16:30:53
Documents
12
Period of Report
2022-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K allk-20220331.htm   iXBRL 8-K 46853
  Complete submission text file 0000950170-22-005374.txt   160124

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20220331_pre.xml EX-101.PRE 9543
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20220331.xsd EX-101.SCH 2492
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20220331_lab.xml EX-101.LAB 12890
6 EXTRACTED XBRL INSTANCE DOCUMENT allk-20220331_htm.xml XML 4514
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 22807367
SIC: 2834 Pharmaceutical Preparations